Nrf2基因失活可阻止大鼠肝癌营养模型中的起始细胞克隆扩增
在大鼠二乙基亚硝胺(DENA)加胆碱缺乏蛋氨酸缺乏(CMD)饮食的肝癌模型中,Nrf2激活见于GSTP阳性癌前病变,65.7%的GSTP阳性灶存在Nrf2错义突变。Nrf2基因敲除不改变DENA诱导的起始,但导致肝损伤增加和慢性代偿性肝细胞再生;尽管环境允许,Nrf2敲除大鼠肝脏未出现任何癌前病变,而野生型大鼠出现。结论认为Nrf2对起始细胞克隆扩增和肝细胞癌发生至关重要。
要点
- Nrf2激活发生于GSTP阳性早期癌前病变,65.7%的GSTP阳性灶存在Nrf2错义突变。
- Nrf2基因敲除不改变DENA诱导的起始,但增加肝损伤和慢性代偿性肝细胞再生。
- 在CMD饮食下,Nrf2敲除大鼠肝脏未出现癌前病变,而野生型大鼠出现。
核心结论
- 在类似人类非酒精性脂肪性肝病的肝癌模型中,Nrf2在肿瘤过程的早期步骤被激活,并且Nrf2是起始细胞克隆扩增所必需的,表明Nrf2在肝细胞癌发生中起关键作用。
研究设计与样本
- 使用野生型(WT)和Nrf2基因敲除(Nrf2KO)大鼠,给予单次注射二乙基亚硝胺(DENA)后喂食胆碱缺乏蛋氨酸缺乏(CMD)饮食。
- 该实验模型导致严重脂肪肝和伴纤维化的脂肪性肝炎,并能够识别肝癌发生的早期阶段。
主要发现
- Nrf2激活发生于由标记物谷胱甘肽S-转移酶胎盘型(GSTP)识别的早期癌前病变中。
- 已知破坏Keap1-Nrf2结合的Nrf2错义突变存在于65.7%的GSTP阳性灶中。
- Nrf2基因失活不改变DENA诱导的起始,但在大鼠喂食CMD饮食时导致肝损伤增加和慢性代偿性肝细胞再生。
- 尽管存在这种允许性环境,Nrf2KO大鼠的肝脏未显示任何癌前病变,而WT大鼠的肝脏显示癌前病变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Dysregulation of the Keap1-Nrf2 pathway has been observed in experimental and human tumors, suggesting possible roles of the pathway in cancer development. Herein, we examined whether Nrf2 (Nfe2l2) activation occurs at early steps of rat hepatocarcinogenesis, to assess critical contributions of Nrf2 to the onset of hepatocellular carcinoma (HCC). METHODS: We used wild-type (WT) and Nrf2 knockout (Nrf2KO) rats treated with a single injection of diethylnitrosamine (DENA) followed by choline-devoid methionine-deficient (CMD) diet. This experimental model causes massive fatty liver and steatohepatitis with fibrosis and enables identification of early stages of hepatocarcinogenesis. RESULTS: We found that Nrf2 activation takes place in early preneoplastic lesions identified by the marker glutathione S-transferase placental form (GSTP). Nrf2 missense mutations, known to disrupt the Keap1-Nrf2 binding, were present in 65.7% of GSTP-positive foci. Nrf2KO rats were used to directly investigate whether Nrf2 is critical for initiation and/or clonal expansion of DENA-damaged hepatocytes. While Nrf2 genetic inactivation did not alter DENA-induced initiation, it led to increased liver injury and chronic compensatory hepatocyte regeneration when rats were fed a CMD diet. However, in spite of such a permissive environment, the livers of Nrf2KO rats did not display any preneoplastic lesion unlike those of WT rats. CONCLUSIONS: These results demonstrate that, in a model of hepatocarcinogenesis resembling human non-alcoholic fatty liver disease: i) Nrf2 is activated at early steps of the tumorigenic process and ii) Nrf2 is mandatory for the clonal expansion of initiated cells, indicating that Nrf2 is critical in the onset of HCC. LAY SUMMARY: Dysregulation of the Keap1-Nrf2 molecular pathway has been observed in human tumors. In a nutritional model of hepatocarcinogenesis, the protein Nrf2 is frequently mutated/activated at early steps of the tumorigenic process. Herein, we show that Nrf2 is mandatory for the development of preneoplastic lesions. These results suggest that Nrf2 has a critical role in the onset of hepatocellular carcinoma.
引用
- Orrù C, Szydlowska M, Taguchi K, et al. Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis. J Hepatol. 2018. PMID: 29758334. doi:10.1016/j.jhep.2018.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。